Home › Funds › PAYDEN & RYGEL › MRK

PAYDEN & RYGEL position in MRK

MERCK & CO · Health Care

PAYDEN & RYGEL reported holding 200,660 shares of MRK (MERCK & CO) in its Q3 2026 13F filing — a position valued at US$29.2M, representing 2.28% of its reported portfolio and ranking #9 among its reported holdings. PAYDEN & RYGEL has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)200.66K sh
Reported value held$29.16M
Portfolio Weight2.28%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How PAYDEN & RYGEL's MRK position evolved

PAYDEN & RYGEL first disclosed a stake in MRK in Q3 2023 at 166,850 shares (US$17.2M). The position peaked in Q3 2026 at 200,660 shares, worth US$29.2M. Across 13 filings, PAYDEN & RYGEL increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 200,660 shares valued at US$29.2M. Notable position changes include a 54% increase in Q3 2024 (shares fell 12% over the following quarter), a 93% trim in Q1 2025 (shares fell 11% over the following quarter), a 5235% increase in Q3 2025 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 166.85K $17.18M New
Q4 2023 166.85K $18.19M Hold
Q1 2024 131.75K $17.38M Reduce
Q2 2024 120.15K $14.88M Reduce
Q3 2024 185.15K $21.03M Add
Q4 2024 111.55K $11.10M Reduce
Q1 2025 7.41K $665.00K Reduce
Q2 2025 3.71K $294.00K Reduce
Q3 2025 197.91K $16.61M Add
Q4 2025 198.10K $20.85M Hold
Q1 2026 198.10K $23.83M Hold
Q2 2026 200.96K $25.82M Add
Q3 2026 200.66K $29.16M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRK and 13F data

MRK (MERCK & CO) is a Health Care company. 30 other funds we track also report a position in MRK — the largest reported positions include BlackRock Inc (US$29.17B), Vanguard Group (US$26.77B), VANGUARD CAPITAL MANAGEMENT LLC (US$23.47B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRK

All MRK fund holders →

FAQ

How long has PAYDEN & RYGEL held MRK?

PAYDEN & RYGEL has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is PAYDEN & RYGEL's current position in MRK?

As of Q3 2026, PAYDEN & RYGEL holds 200.66K shares of MRK (MERCK & CO), valued at $29.16M, representing 2.28% of its reported portfolio and ranking #9.

Has PAYDEN & RYGEL been buying or selling MRK?

In the latest 13F filing (Q3 2026), PAYDEN & RYGEL held unchanged its position in MRK. The position peaked in Q3 2026 at 200.66K shares.

Which other funds hold MRK?

Other major institutional holders of MRK include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.